Additionally, LOC101928222, through the m6A-dependent pathway, cooperates with IGF2BP1 to stabilize HMGCS2 mRNA, thus promoting cholesterol synthesis and ultimately driving CRC progression [16]. Here, IGF2BP1 is linked to colorectal carcinoma.